Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/2637 stock hub

HKG/2637 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2637is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.6B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2637

In the news

Latest news · HKG/2637

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E85.8

P25 11.7P50 18.9P75 41.4

Trailing P/E83.3

P25 10.7P50 17.9P75 38.5

ROE16.6

P25 -14.7P50 2P75 9.4

ROIC49.2

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2637 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

134

Groups with data

Currency

CNY

Showing 134 of 134 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	164
Enterprise value	HKD 17.2B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	HKD 18.6B
Price	HKD 236
Price currency	HKD
Sector	Healthcare
Sic	2834
Symbol	hkg/2637
Website	https://www.hxpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.06%
EV Earnings	87.4x
EV/EBIT	80.47x
EV/EBITDA	79.26x
EV/Sales	26.57x
Forward P/E	85.78x
P/B ratio	10.47x
P/E ratio	83.27x
P/S ratio	28.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	33.01%
EBITDA Margin	33.52%
Gross margin	83.38%
Gross Profit	HKD 540.3M
Net Income	HKD 197M
Pretax Margin	34.01%
Profit Margin	30.4%
ROA	9.23
ROCE	11.88
ROE	16.58
ROIC	49.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	24.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.45
Assets	HKD 2.1B
Cash	HKD 1.5B
Current Assets	HKD 1.7B
Current Liabilities	HKD 262.9M
Debt	HKD 122.6M
Debt EBITDA	HKD 0.56
Debt Equity	HKD 0.07
Equity	HKD 1.8B
Interest Coverage	33.52
Liabilities	HKD 281.5M
Long Term Assets	HKD 396.2M
Long Term Liabilities	HKD 18.6M
Net Cash	HKD 1.4B
Net Cash By Market Cap	HKD 7.31
Net Debt EBITDA	HKD -6.25
Net Debt Equity	HKD -0.77
Tangible Book Value	HKD 1.8B
Tangible Book Value Per Share	HKD 22.53

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.31
Inventory Turnover	2.12
Net Working Capital	HKD -36.3M
Quick ratio	6.06
Working Capital	HKD 1.3B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	178.9
All Time High	302.4
All Time High Change	-21.96%
All Time High Date	2026-04-28
All Time Low	97.5
All Time Low Change	142.05%
All Time Low Date	2025-10-22
ATR	23.78
Beta1y	0.93
Ch YTD	73.53
High	252.4
High52	302.4
High52 Date	2026-04-28
High52ch	-21.96%
Low	235
Low52	97.5
Low52 Date	2025-10-22
Low52ch	142.05%
Ma50ch	31.89%
RSI	56.13
RSI Monthly	0
RSI Weekly	78.14
Sharpe ratio	2.37x
Sortino ratio	4.1
Tr YTD	73.53
Tr1m	33.56%
Tr1w	-7.16%
Tr3m	73.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 213.9M
Operating margin	33.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,270,310%
Shares Insiders	28.8%
Shares Institutions	6.04%
Shares Out	78,707,270

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	508,947.7x
Bv Per Share	22.53
Ch1m	33.56
Ch1w	-7.16
Ch3m	73.79
Ch6m	92.18
Change	-6.87%
Change From Open	-5.83
Close	253.4
Days Gap	-1.1
Depreciation Amortization	3,372,928.2
Dollar Volume	87,532,400
Earnings Date	2026-03-30
EBIT	HKD 213.9M
EBITDA	HKD 217.2M
EPS	HKD 2.83
F Score	2
Fiscal Year End	December
Founded	2,012
Graham Number	37.90717
Graham Upside	-83.94
Income Tax	HKD 23.4M
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Ma20	221.3
Ma20ch	6.66%
Open	250.6
Position In Range	5.75
Ppne	378,191,731.1
Price Date	2026-05-08
Price EBITDA	HKD 85.52
Ptbv Ratio	10.47
Relative Volume	0.73x
Revenue	648,053,950x
Tax By Revenue	3.61x
Tax Rate	10.63%
Tr6m	92.18%
Volume	370,900

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2637 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/2637?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.0%

Share of float held by funds and institutions

Insider ownership

+28.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/2637 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.1

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2637

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2637 stock rating?

hkg/2637 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2637 analysis?

The full report lives at /stocks/hkg/2637/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2637?

The latest report frames hkg/2637 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2637 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.